GC
RXDX

Guggenheim Capital’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Guggenheim Capital’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-14,103
Closed -$1.51M – 1964
2023
Q1 		$1.51M Buy
14,103
+8,664
+159% +$930K 0.01% 973
2022
Q4 		$598K Buy
+5,439
New +$598K 0.01% 1402